1. HIV antiretroviral therapy;Kemnic,2021
2. Risks and benefits of reducing the number of drugs to treat HIV-1 infection;Cadiñanos;Expert Opin Drug Saf,2021
3. Optimizing antiretroviral therapy in treatment-experienced patients living with HIV: a critical review of switch and simplification strategies. An opinion of the HIV Practice and Research Network of the American College of Clinical Pharmacy;Chastain;J Int Assoc Provid AIDS Care,2019
4. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV developed by the DHHS Panel on Antiretroviral Guidelines for Adults 2022, https://clinicalinfo.hiv.gov/sites/default/files/https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf; [Accessed 28 July 2022].
5. European AIDS Clinical Society. European AIDS Clinical Society (EACS) Guidelines 10.1 October 2020. Version 10.1. 2020, https://www.eacsociety.org/files/guidelines-10.1_30032021_1.pdf; [Accessed 28 July 2022].